NICE, SIGN and RCGP publish guidelines scope for Long Covid
In a welcome announcement, the guidelines will address a lot of the uncertainty around post-Covid syndrome, aka Long Covid, defined as the signs and symptoms that develop during or following an infection consistent with Covid-19 which continue for more than 12 weeks and are not explained by an alternative diagnosis.
The scope refers to the vast array of variable symptoms, including mental health problems, lethargy, myalgia and persistent pyrexia. The ambitious aim of the scope is to include: when to refer, pharmacological and non-pharmacological interventions and best practices for recovery and rehabilitation services.
I’m heartened by this announcement and hope that when this is delivered, it is as unambiguous as it can possibly be. Many of my primary and secondary care colleagues are struggling with the uncertainty of this diagnosis, largely driven by the fear of misdiagnosis.